DKCM
HUMA icon

Davidson Kempner Capital Management’s Humacyte HUMA Stock Holding History

Davidson Kempner Capital Management’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.9M Buy
+5,000,000
New +$4.63M 0.05% 166
2023
Q3 		– Sell
-450,000
Closed -$1.28M – 302
2023
Q2 		$1.28M Buy
+450,000
New +$1.62M 0.02% 158

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Davidson Kempner Capital Management's HUMA Position: Q2 2026 in Review

Davidson Kempner Capital Management opened a new position in Humacyte (HUMA) in Q2 2026: 5,000,000 shares worth $3.9M. The stake represents 0.05% of the portfolio and ranks #166 among its holdings. This is a return to the name: Davidson Kempner Capital Management previously reported a position in HUMA as recently as Q2 2023.

Davidson Kempner Capital Management first reported a position in HUMA in Q2 2023 and has held it in 2 quarters since. 163 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Davidson Kempner Capital Management held 5,000,000 shares of Humacyte worth $3.9M as of Q2 2026.
  • Humacyte was a new Davidson Kempner Capital Management position in Q2 2026.
  • Humacyte made up 0.05% of Davidson Kempner Capital Management's portfolio in Q2 2026, its #166 holding.
  • Davidson Kempner Capital Management first reported a position in Humacyte in Q2 2023 and has held it in 2 quarters since.
  • 163 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Davidson Kempner Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.